The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. The role requires strong cross-functional collaboration to ensure seamless execution of strategy and tactics, working closely with Sales, Sales Training, Market Research, Regulatory, Legal, Medical Affairs, Managed Markets, and agency partners.